"Dexamethasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory 9-fluoro-glucocorticoid.
Descriptor ID |
D003907
|
MeSH Number(s) |
D04.210.500.745.432.769.344 D04.210.500.908.238
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dexamethasone".
Below are MeSH descriptors whose meaning is more specific than "Dexamethasone".
This graph shows the total number of publications written about "Dexamethasone" by people in this website by year, and whether "Dexamethasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2001 | 1 | 1 | 2 |
2002 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2008 | 0 | 2 | 2 |
2010 | 3 | 1 | 4 |
2011 | 1 | 1 | 2 |
2012 | 1 | 1 | 2 |
2014 | 1 | 1 | 2 |
2015 | 1 | 1 | 2 |
2016 | 1 | 5 | 6 |
2017 | 29 | 32 | 61 |
2018 | 27 | 19 | 46 |
2019 | 9 | 8 | 17 |
2020 | 16 | 32 | 48 |
2021 | 22 | 28 | 50 |
To return to the timeline, click here.
Below are the most recent publications written about "Dexamethasone" by people in Profiles.
-
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study. Clin Infect Dis. 2021 12 06; 73(11):2031-2036.
-
Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality. Clin Infect Dis. 2021 12 06; 73(11):2116-2118.
-
From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19? J Immunotoxicol. 2021 12; 18(1):23-29.
-
Pulse steroid treatment for hospitalized adults with COVID-19 Turk J Med Sci. 2021 10 21; 51(5):2248-2255.
-
Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019. J Infect Dis. 2021 09 17; 224(6):934-937.
-
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study. PLoS One. 2021; 16(9):e0256977.
-
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1407-1418.
-
COVID-19: potential therapeutics for pediatric patients. Pharmacol Rep. 2021 Dec; 73(6):1520-1538.
-
Asthma and COVID-19: Emphasis on Adequate Asthma Control. Can Respir J. 2021; 2021:9621572.
-
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study. Ann Intern Med. 2021 10; 174(10):1395-1403.